GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 100 filers reported holding GENERATION BIO CO in Q4 2022. The put-call ratio across all filers is 5.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10 | -33.3% | 2,769 | +4.0% | 0.00% | – |
| Q2 2023 | $15 | +25.0% | 2,662 | -1.5% | 0.00% | – |
| Q1 2023 | $12 | -88.2% | 2,702 | -89.6% | 0.00% | – |
| Q4 2022 | $102 | -99.9% | 26,037 | +0.0% | 0.00% | – |
| Q3 2022 | $138,000 | -18.8% | 26,033 | +0.4% | 0.00% | – |
| Q2 2022 | $170,000 | +33.9% | 25,917 | +50.1% | 0.00% | – |
| Q1 2022 | $127,000 | -43.0% | 17,268 | -45.1% | 0.00% | – |
| Q4 2021 | $223,000 | -71.8% | 31,468 | -0.4% | 0.00% | -100.0% |
| Q3 2021 | $792,000 | -24.9% | 31,610 | -19.4% | 0.00% | 0.0% |
| Q2 2021 | $1,055,000 | +66.9% | 39,227 | +76.7% | 0.00% | 0.0% |
| Q1 2021 | $632,000 | +98.7% | 22,200 | +98.2% | 0.00% | – |
| Q4 2020 | $318,000 | +83.8% | 11,200 | +100.0% | 0.00% | – |
| Q3 2020 | $173,000 | – | 5,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |